🇺🇸 FDA
Pipeline program

Vedolizumab

2024P000152

Phase 2 mab active

Quick answer

Vedolizumab for Collagenous Gastritis is a Phase 2 program (mab) at TAKEDA PHARMACEUTICAL CO LTD with 1 ClinicalTrials.gov record(s).

Program details

Company
TAKEDA PHARMACEUTICAL CO LTD
Indication
Collagenous Gastritis
Phase
Phase 2
Modality
mab
Status
active

Clinical trials